Cargando…

CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib

OBJECTIVES: To analyse the predictive value of the volume of enhancement of disease (VED), based on the CT arterial enhancement coefficient (ΔArt%), in the evaluation of the sorafenib response in patients with advanced hepatocellular carcinoma (HCC). METHODS: Patients with sorafenib-treated advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colagrande, S., Calistri, L., Campani, C., Dragoni, G., Lorini, C., Nardi, C., Castellani, A., Marra, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Hepatobiliary-Pancreas
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880966/ https://www.ncbi.nlm.nih.gov/pubmed/32827266 http://dx.doi.org/10.1007/s00330-020-07171-3

Ejemplares similares

Correction to: CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib
por: Colagrande, S., et al.
Publicado: (2020)

Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis
por: Chen, Jifan, et al.
Publicado: (2020)

Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5(th) edition of the World Health Organization classification
por: Auer, Timo A., et al.
Publicado: (2023)

Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy
por: Cheung, Helen M. C., et al.
Publicado: (2018)

Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study
por: Wei, Hong, et al.
Publicado: (2023)

CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control
por: Joo, Ijin, et al.
Publicado: (2022)

Magnetic resonance imaging of inflammatory pseudotumor of the liver: a 2021 systematic literature update and series presentation
por: Calistri, Linda, et al.
Publicado: (2022)

Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions
por: Reimer, R. P., et al.
Publicado: (2020)

The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study
por: Poetter-Lang, Sarah, et al.
Publicado: (2018)

Comparison between dynamic gadoxetate-enhanced MRI and (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function
por: Rassam, F., et al.
Publicado: (2019)

Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI
por: Poetter-Lang, Sarah, et al.
Publicado: (2022)

Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study
por: Poetter-Lang, Sarah, et al.
Publicado: (2023)

Computed high-b-value high-resolution DWI improves solid lesion detection in IPMN of the pancreas
por: Harder, Felix N., et al.
Publicado: (2023)

Parametric exploration of the liver by magnetic resonance methods
por: Sijens, Paul E.
Publicado: (2009)

Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis
por: Ishibashi, Hiroyuki, et al.
Publicado: (2011)

Pure Pancreaticocutaneous Fistula Shunted Into the Urinary Bladder. Lesson Learned by an Incomplete, Original Attempt
por: Violi, Vincenzo, et al.
Publicado: (2014)

Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times
por: Cieszanowski, Andrzej, et al.
Publicado: (2012)

Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study
por: Huang, Mingsheng, et al.
Publicado: (2016)

Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial
por: Zech, Christoph J., et al.
Publicado: (2016)

Post-hepatectomy liver failure after major hepatic surgery: not only size matters
por: Asenbaum, Ulrika, et al.
Publicado: (2018)

Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk
por: Fotiadis, Nicos, et al.
Publicado: (2020)

Combined hepatocellular-cholangiocarcinoma: which preoperative clinical data and conventional MRI characteristics have value for the prediction of microvascular invasion and clinical significance?
por: Wang, Xiaolong, et al.
Publicado: (2020)

Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis—a preclinical study using caval subtraction phase-contrast and cardiac MRI
por: Chouhan, Manil D., et al.
Publicado: (2020)

Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis
por: An, Chao, et al.
Publicado: (2021)

Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm
por: Chong, Huan-Huan, et al.
Publicado: (2021)

Hyperlipasemia in Hospitalized COVID-19 Patients
por: Kenner, Maria, et al.
Publicado: (2021)

The Impact of COVID-19 on Time-to-treatment in Pancreatic Adenocarcinoma: A Single Institutional Experience
por: Sugumar, Kavin, et al.
Publicado: (2021)

Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE
por: Foley, Kieran G., et al.
Publicado: (2021)

Evaluation of a single-breath-hold radial turbo-spin-echo sequence for T2 mapping of the liver at 3T
por: Bencikova, Diana, et al.
Publicado: (2021)

Stent placement combined with intraluminal radiofrequency ablation and hepatic arterial infusion chemotherapy for advanced biliary tract cancers with biliary obstruction: a multicentre, retrospective, controlled study
por: Gou, Qing, et al.
Publicado: (2021)

Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
por: Auer, Timo Alexander, et al.
Publicado: (2020)

Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
por: Pozzi Mucelli, Raffaella M., et al.
Publicado: (2022)

Comparison of a preoperative MR-based recurrence risk score versus the postoperative score and four clinical staging systems in hepatocellular carcinoma: a retrospective cohort study
por: Wei, Hong, et al.
Publicado: (2022)

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
por: Lampichler, Katharina, et al.
Publicado: (2022)

Apparent diffusion coefficient correlates with different histopathological features in several intrahepatic tumors
por: Surov, Alexey, et al.
Publicado: (2023)

A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features
por: Shen, Keren, et al.
Publicado: (2023)

MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma
por: Kupczyk, Patrick Arthur, et al.
Publicado: (2023)

Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
por: Pal Chaudhary, Surendra, et al.
Publicado: (2023)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n2uku9cpng5pod0fiij73f88jc